194 related articles for article (PubMed ID: 10459728)
1. Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging.
Panousis C; Pietersz GA
Drugs Aging; 1999 Jul; 15(1):1-13. PubMed ID: 10459728
[TBL] [Abstract][Full Text] [Related]
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody drug conjugates in the treatment of cancer.
Trail PA; Bianchi AB
Curr Opin Immunol; 1999 Oct; 11(5):584-8. PubMed ID: 10508711
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in cancer therapy.
Oldham RK
J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
[TBL] [Abstract][Full Text] [Related]
7. New insights into the pretargeting approach to image and treat tumours.
Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
[TBL] [Abstract][Full Text] [Related]
8. Antibody-targeted drugs for the therapy of cancer.
Pietersz GA; Krauer K
J Drug Target; 1994; 2(3):183-215. PubMed ID: 7812691
[TBL] [Abstract][Full Text] [Related]
9. Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
Zangemeister-Wittke U
Pathobiology; 2005; 72(6):279-86. PubMed ID: 16582579
[TBL] [Abstract][Full Text] [Related]
10. Immunoconjugates: lessons from animal models.
Canevari S; Colombatti M; Colnaghi MI
Ann Oncol; 1994 Oct; 5(8):698-701. PubMed ID: 7826901
[TBL] [Abstract][Full Text] [Related]
11. Review: advances in monoclonal antibody tumour targeting.
Kosmas C; Linardou H; Epenetos AA
J Drug Target; 1993; 1(2):81-91. PubMed ID: 8069556
[TBL] [Abstract][Full Text] [Related]
12. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
[TBL] [Abstract][Full Text] [Related]
13. An overview of monoclonal antibody therapy of cancer.
Weiner LM
Semin Oncol; 1999 Aug; 26(4 Suppl 12):41-50. PubMed ID: 10482193
[TBL] [Abstract][Full Text] [Related]
14. [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].
Alfaro C; Murillo O; Tirapu I; Azpilicueta A; Huarte E; Arina A; Arribillaga L; Pérez-Gracia JL; Bendandi M; Prieto J; Lasarte JJ; Melero I
An Sist Sanit Navar; 2006; 29(1):77-96. PubMed ID: 16670731
[TBL] [Abstract][Full Text] [Related]
15. Tumour-targeted chemotherapy with immunoconjugates of calicheamicin.
Damle NK
Expert Opin Biol Ther; 2004 Sep; 4(9):1445-52. PubMed ID: 15335312
[TBL] [Abstract][Full Text] [Related]
16. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
17. Antibody conjugate therapeutics: challenges and potential.
Teicher BA; Chari RV
Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
[TBL] [Abstract][Full Text] [Related]
18. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
[TBL] [Abstract][Full Text] [Related]
19. The use of anthracycline-antibody complexes for specific antitumor activity.
Pietersz GA; Smyth MJ; Farquhar I; McKenzie C
Targeted Diagn Ther; 1988; 1():25-53. PubMed ID: 2979059
[No Abstract] [Full Text] [Related]
20. Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates.
Jackson D; Stover D
Pharm Res; 2015 Nov; 32(11):3458-69. PubMed ID: 25339341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
